valneva chikungunya vaccine - Search News

Order byBest matchMost fresh

News

FDA Suspends Valneva Vaccine's License

MedCity News · 1d

FDA Suspends Valneva Vaccine’s License Following New Reports of Adverse Events

Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a pause on dosing of Ixchiq, but the agency’s new safety alert is based on an assessment that found the vaccine appears to be causing chikungunya-like illness in recipients.

Continue reading

· 2d · on MSN

FDA suspends Valneva's chikungunya vaccine license in the U.S

FDA suspends license for chikungunya vaccine Ixchiq over serious safety concerns

1don MSN

Valneva shares tumble after suspension of US chikungunya vaccine licence

Shares of French drugmaker Valneva slumped more than 20% on Monday after the U.S. Food and Drug Administration suspended the ...

MedPage Today on MSN21h

In Abrupt Reversal, FDA Yanks Ixchiq Vaccine Over Safety Concern

According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results